EGFR and hepatocellular carcinoma: In order to determine whether the activation of EGFR contributes to the upregulation of PD-L1 in HCC cells, we first knocked down of EGFR with specific shRNA in SNU-368 cells and evaluated the expression of EGF-mediated PD-L1 expression.